$1,039 – $2,139

11th International Virology and Infectious Diseases Congress (CSE) A

Event Information

Share this event

Date and Time

Location

Location

Vancouver

Vancouver, BC

Canada

View Map

Refund Policy

Refund Policy

No Refunds

Event description

Description

About Conference

Conference series pleased to announce “11th Virology and Infectious Diseases Congress” held during July 27-28, 2018 Vancouver, Canada. We are happy to invite all anticipated participants to share and explore their research findings as Keynote presentations, Oral talks, Poster presentations, Symposiums, Workshops and Exhibitions.

Virology Congress 2018 will focus on the latest and exciting innovations in all areas of Virology and Infectious Diseases research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. This Virology Congress 2018 also encourages the active participation of young student researchers as we are hosting Poster Award Competition and Young research Forum at the conference venue. Virology is often considered a part of microbiology or of pathology. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of Microbiology especially Clinical and Diagnostic Microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health. Viruses and viral diseases have been at the centers of science, agriculture, and medicine for millennia and some of our greatest challenges and triumphs have involved virology. The advent of the HIV pandemic led to a dramatic increase in research in the field of rational drug design, resulting in the large number of antiviral drugs and vaccines entering clinical trials today.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases. Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B ( 1.1million), Malaria(2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million), Respiratory Infections (4.4 million).

Target Audience:

Virology Students, Scientists

· Virology Researchers

· Virology Faculty

· Dean and Directors

· Pharmaceutical Industries

· Microbiologists

· Health Care Professionals

· Bacteriologists

· Epidemiologists

· Virology Associations and Societies

· Doctors

· International AIDS Society

· Infection Prevention and Infection Control Specialists

· Experts and Delegates

· Virologists

· Parasitologists

Why to attend?

Virology Congress 2018 provide a global platform for exchanging ideas and make us updated about the New Technologies Emerging in Virology & Infectious Diseases. It is the best Opportunity to attend the presentations delivered by Eminent Scientists from all over the world. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2 days event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Why Vancouver?

Vancouver is a coastal seaport city in Canada, located in the Lower Mainland region of British Columbia. As the most populous city in the province & one of North America’s most cosmopolitan cities. Vancouver as “a world-class city with ocean attached”. Stanley Park is one of the world’s largest (1,000 acres) and most beautiful urban green spaces. Must-sees include the nine towering totem poles at Brockton Point. The Greater Vancouver area had a population of 2,463,431 in 2016, making it the third-largest metropolitan area in Canada. The Economist Intelligence Unit acknowledged it as the first city ranked among the top-ten of the world's most well-living cities for five consecutive years.

Vancouver has hosted many international conferences and events, including the 1954 British Empire and Commonwealth Games, UN Habitat I, Expo 86, the World Police and Fire Games in 1989 and 2009; and the 2010 Winter Olympics and Paralympics which were held in Vancouver and Whistler, a resort community 125 km (78 mi) north of the city. The City of Vancouver was one of the first cities in Canada to enter into an international sister cities arrangement.

Market Analysis

Summary: 11th International Virology and Infectious Diseases Congress takes immense pleasure to welcome attendees, presenters, and exhibitors from all over the world to Canada. We are delighted to have you all at the “Virology Congress 2018” which is going to be held during July 27-28, 2018 at Vancouver, Canada. The organizing committee is accelerating for an advanced and informative conference program including plenary speech, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We welcome you to join us at the Virology Congress 2018, where you will be sure to have a delighted experience with scholars from all around the world. All the members of Virology Congress 2018 organizing committee look forward to meet you at Canada.

The global virology market is expected to bloom over 2015-2025. In 2015, the virology industry was highly influenced by Ebola, MERS, and hepatitis C viruses. In 2016, zika virus is dominating the research, with more better prospects in the near future. By 2017 end, a few important patents are approaching expiry, including Tamiflu, Sustiva, Tenofovir, Combivir, Relenza, and Telbivudine. With the expiry of these blockbuster drugs, the market is estimated to encounter a dynamic competitive landscape. The generic competition in the virology market will be in this high pace from 2018 onward. Europe is projected to maintain the position as the second largest market globally. During the forecast periods, USA is anticipated to record the highest CAGR, governed by enhanced healthcare infrastructure, access to diagnostics, and enhanced affordability of diagnostic tests for viral diseases.


Renowned Speakers

Jean-Marie Andrieu

Jean-Marie Andrieu

University of Paris-Descartes , France

Jelena Prpic

Jelena Prpic

Croatian Veterinary Institute, Croatia

Jiehao Cai

Jiehao Cai

Children’s Hospital of Fudan University, China

Jingrang Lu

Jingrang Lu

EPA Environmental Protection Agency , USA

Jizhong Zhou

Jizhong Zhou

University of Oklahoma, USA

Joachim Wink

Joachim Wink

Helmholtz Centre for Infection Research, Germany

John G Thomas

John G Thomas

West Virginia University, USA

Jorge C. Blanco

Jorge C. Blanco

Sigmovir Biosystems Inc, USA

Jose Esparza

Jose Esparza

Bill & Melinda Gates Foundation , USA

Juana Díez

Juana Díez

Pompeu Fabra University, Spain

Kamaleldin B Said

Kamaleldin B Said

Carleton University, Canada

Kathrin Mohr

Kathrin Mohr

Helmholtz Centre for Infection Research, Germany

Kay Taylor

Kay Taylor

Founder/Ambassador Preventing Cervical Cancer (PINCC), USA

Khaled Barakat

Khaled Barakat

University of Alberta, Canada

Kunihiro Kaihatsu

Kunihiro Kaihatsu

Osaka University, Japan

Larry Kauvar

Larry Kauvar

Trellis Bioscience, USA

Lenore Pereira

Lenore Pereira

University of California San Francisco, USA

Lisa Lindesmith

Lisa Lindesmith

University of North Carolina, USA

Liying Yang

Liying Yang

New York University School of Medicine, USA

Louise Cosby

Louise Cosby

Queen’s University, UK

Mahdi Saeed

Mahdi Saeed

Michigan State University, USA

Mahin Khatami

Mahin Khatami

National Cancer Institute, USA

Malgorzata G Norton

Malgorzata G Norton

U.S. Food and Drug Administration, USA

Manfred Hochleithner

Manfred Hochleithner

VÖK, Austria

Marc H.V. Van Regenmortel

Marc H.V. Van Regenmortel

University of Strasbourg, France

Marcin Sieńczyk

Marcin Sieńczyk

Wroclaw University of Technology, Poland

Margitta Dathe

Margitta Dathe

Leibniz Institute of Molecular Pharmacology, Germany

Daniela Maria Cirillo

Daniela Maria Cirillo

San Raffaele Scientific Institute Milan, Italy

Mark Enright

Mark Enright

Manchester Metropolitan University, UK

Masataka

Masataka

Tohoku University, Japan

Massimo Ciccozzi

Massimo Ciccozzi

Istituto Superiore di Sanità, Italy

Massimo Clementi

Massimo Clementi

University Vita-Salute San Raffaele, Italy

Michael W. Washabaugh

Michael W. Washabaugh

MedImmune, USA

Miklas Scholz

Miklas Scholz

Civil Engineering Stanford University, UK

Mohammad Hossain

Mohammad Hossain

Kansas State University, USA

Mohammad Mir

Mohammad Mir

Western University of Health Science, USA

Mohannad AL-Saghir

Mohannad AL-Saghir

Ohio University Zanesville, USA

Mugdha Vasireddi

Mugdha Vasireddi

Georgia State University, USA

Natalia Tschowri

Natalia Tschowri

Humboldt-Universität zu Berlin, Germany

Nataliya Piletska

Nataliya Piletska

Evelina Children’s Hospital, UK

Natascia Bruni

Natascia Bruni

Candioli Pharma Organization, Italy

Nicola Petrosillo

Nicola Petrosillo

National Institute for Infectious Diseasesx, Italy

Niels Norskov-Lauritsen

Niels Norskov-Lauritsen

Aarhus University Hospital, Denmark

Nikos E Mavroudis

Nikos E Mavroudis

Northumbria University, UK

Olga S. Latinovic

Olga S. Latinovic

University of Maryland, USA

Palina Vyhouskaya

Palina Vyhouskaya

Jagiellonian University, Poland

Paola Grandi

Paola Grandi

University of Pittsburgh, USA

Patrick J Brennan

Patrick J Brennan

Colorado State University, USA

Pedro Brandao dos Santos Pedrosa

Pedro Brandao dos Santos Pedrosa

Leibniz Universität, Germany

Peter Proksch

Peter Proksch

Istitute of Pharmaceutical Biology and Biotechnology at the University of Düsseldorf, Germany

Piero Mastroeni

Piero Mastroeni

Infection and Immunity University of Cambridge United Kingdom, UK

Polly Roy

Polly Roy

London School of Hygiene and Tropical Medicine, UK

Qiao Sun

Qiao Sun

Shanghai Pudong New Area Center for Disease Control and Prevention, China

Rajesh Sani

Rajesh Sani

South Dakota School of Mines and Technology, USA

Rajinder S. Ranu

Rajinder S. Ranu

Colorado State University, USA

Raquel Rodrigues

Raquel Rodrigues

Umeå University, Sweden

Roby P. Bhattacharyya

Roby P. Bhattacharyya

Broad Institute of MIT and Harvard , USA

Ronald Moss

Ronald Moss

Ansun Biopharma, USA

Rossella Colomba Lelli

Rossella Colomba Lelli

Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise “G. Caporale”, Italy

Ruma Mukerjee

Ruma Mukerjee

Temple University, USA

Ruth M. Ruprecht

Ruth M. Ruprecht

Texas Biomedical Research Institute , USA

Samira Khiar

Samira Khiar

Institute Pasteur, France

Schutzbank Ted

Schutzbank Ted

St.John Providence Health System, Michigan, USA

Ségolène Caboche

Ségolène Caboche

Lille University of Science and Technology, France

Shahana Choudhury

Shahana Choudhury

Meharry Medical College, USA

Shen Kunling

Shen Kunling

Capital Medical University, China

Shubhada Bopegamage

Shubhada Bopegamage

Slovak Medical University, Slovakia

Sita Awasthi

Sita Awasthi

University of Pennsylvania, USA

Suresh K. Mittal

Suresh K. Mittal

Purdue University, USA

Teresa Norris

Teresa Norris

HPV Awareness Corporation/Corporation de Sensibilisation VPH, Canada

Ting-Chao Chou

Ting-Chao Chou

PD Science LLC, USA

Todd E. Bell

Todd E. Bell

Texas Tech University Health Science Center, USA

Tonyia Renee

Tonyia Renee

National Cervical Cancer Coalition/HPV Cancer Coalition, USA

Ulrich Desselberger

Ulrich Desselberger

University of Cambridge, UK

Vladimír Zajac

Vladimír Zajac

Cancer Research Institute, Slovakia

Walter Doerfler

Walter Doerfler

University of Erlangen-Nuernberg & Cologne University, Germany

Wolfgang R.Heizmann

Wolfgang R.Heizmann

Orgamed Consulting / University of Tübingen, Germany

Yen- Lieberman

Yen- Lieberman

Case Western Reserve University in Cleveland, USA

Yolanda Revilla

Yolanda Revilla

Centro de Biología Molecular “Severo Ochoa”, Spain

Yuan Gu

Yuan Gu

Capital Medical University, China

Yu-Zhong Zhang

Yu-Zhong Zhang

Shandong University, China

ZhangLei

ZhangLei

Chinese Academy of Agricultural Sciences, China

Zhiheng Pei

Zhiheng Pei

New York University School of Medicine, USA

Aaron Berliner

Aaron Berliner

Bio/Nano Research Group, USA

Anand Ramasubramanian

Anand Ramasubramanian

University of Texas, USA

Anil Kumar

Anil Kumar

University of Missouri, USA

Chandrika Johnson

Chandrika Johnson

Fayetteville State University, USA

Amaresh Das

Amaresh Das

APHIS-USDA, USA

Amelie Mc Fadyen

Amelie Mc Fadyen

University of Quebec in Montreal, Canada

Amin Fadl

Amin Fadl

University of Wisconsin-Madison, USA

Amparo Gamero Lluna

Amparo Gamero Lluna

University of Valencia, Spain

Amy F.Savage

Amy F.Savage

University of Florida, USA

Ananda M. Chakrabarty

Ananda M. Chakrabarty

University of Illinois, USA

Angelika Krumina

Angelika Krumina

Riga Stradins University, Latvia

Angeliki Mavroidi

Angeliki Mavroidi

General Hospital of Nea Ionia , Greece

Anton Sholukh

Anton Sholukh

Texas Biomedical Research Institute, USA

Antoni Bennasar-Figueras

Antoni Bennasar-Figueras

Universitat de les Illes Balears, Spain

Arnolfo Petruzziello

Arnolfo Petruzziello

IRCCS Fond, Pascale, Italy

Ayman Noreddin

Ayman Noreddin

Chapman University School of Pharmacy, USA

Bożena Futoma-Kołoch

Bożena Futoma-Kołoch

University of Wrocław, Poland

Brent E. Korba

Brent E. Korba

Georgetown University Medical Centre, USA

Brian L Pearlman

Brian L Pearlman

Atlanta Medical Center,, USA

Carlos Alberto Guzman

Carlos Alberto Guzman

Helmholtz Centre for Infection Research, Germany

Charles J. Russell

Charles J. Russell

St. Jude Children’s Research Hospital, USA

Charles William Keevil

Charles William Keevil

University of Southampton Centre for Biological Sciences, UK

Chil-Yong Kang

Chil-Yong Kang

Western University, Canada

Choong-Min Kang

Choong-Min Kang

California State University, USA

Chuanling Zhang

Chuanling Zhang

Peking University, China

Chunyan Liu

Chunyan Liu

Capital Medical University, China

Claudia Vuotto

Claudia Vuotto

Microbial Biofilm Laboratory, Italy

Claudio Galli

Claudio Galli

Medical Scientific Liaison Europe,Abbott Diagnostics, Italy

Dagmar Schoder

Dagmar Schoder

University of Veterinary Medicine, Austria

Daniela Maria Cirillo

Daniela Maria Cirillo

San Raffaele Scientific Institute Milan, Italy

Darron R. Brown

Darron R. Brown

Indiana University School of Medicine, USA

David Vigerust

David Vigerust

Vanderbilt University, USA

Eckard Wimmer

Eckard Wimmer

Stony Brook University, USA

Edward J Woznaik

Edward J Woznaik

State Veterniarian and Lieutetnant , USA

Elena V Orlova

Elena V Orlova

University of London, UK

Elisabeth Carniel

Elisabeth Carniel

Institut Pasteur , France

Estanislao Nistal-Villán

Estanislao Nistal-Villán

University of Navarra, Spain

Farshad Guirakhoo

Farshad Guirakhoo

GeoVax, USA

Fernando de la Calle

Fernando de la Calle

PharmaMar, Spain

Filippo De Nicolellis

Filippo De Nicolellis

Fiumcello,Friuli Venezia Giulia, Italy

Fiona McPhee

Fiona McPhee

Bristol-Myers Squibb Co, USA

Franco Lori

Franco Lori

ViroStatics srl , Italy

Francois Dufrasne

Francois Dufrasne

Universite Catholique de Louvain, Belgium

Friedrich Goetz

Friedrich Goetz

University Tübingen, Germany

George Adigbli

George Adigbli

University College London, UK

Geraldine Durand

Geraldine Durand

BioMérieux , France

Gianfranco Donelli

Gianfranco Donelli

Microbial Biofilm Laboratory IRCCS Fondazione Santa Lucia , Italy

Giovanni Matera

Giovanni Matera

University of Catanzaro, Italy

Girish J. Kotwal

Girish J. Kotwal

UMass School of Medicine, USA

Giulio Filippo Tarro

Giulio Filippo Tarro

Foundation de Beaumont Bonelli for Cancer Research, Italy

Hiroshi Ohrui

Hiroshi Ohrui

Yokohama University of Pharmacy, Japan

Hua Zhu

Hua Zhu

Rutgers University, USA

Ibrahim M. Banat

Ibrahim M. Banat

University of Ulster, UK

Ilya B Tsyrlov

Ilya B Tsyrlov

XENOTOX Inc, USA

Jagannadha Sastry

Jagannadha Sastry

The University of Texas, USA



Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:

- Multiple participant discounts

- Price quotations or visa invitation letters

- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)

- Event sponsorship


NO REFUNDS ALLOWED ON REGISTRATIONS

Prices may go up any time. Service fees included in pricing.

-----------------------------------------------------------------

This event is brought to you by:

Conferenceseries Ltd. - NewYorkEventsList

http://www.NyEventsList.com

http://www.BostonEventsList.com

http://www.SFBayEventsList.com

-----------------------------------------------------------------

SHU180108CEV

Share with friends

Date and Time

Location

Vancouver

Vancouver, BC

Canada

View Map

Refund Policy

No Refunds

Save This Event

Event Saved